ACLY Antibody (N-term) Blocking Peptide

Catalog Number: ABT-BP6784A
Article Name: ACLY Antibody (N-term) Blocking Peptide
Biozol Catalog Number: ABT-BP6784A
Supplier Catalog Number: BP6784a
Alternative Catalog Number: ABT-BP6784A-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: ATP-citrate synthase, ATP-citrate (pro-S-)-lyase, ACL, Citrate cleavage enzyme, ACLY
ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine.
NCBI: 47
UniProt: P53396
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP6784a was selected from the N-term region of human ACLY. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.